Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Aripiprazole
Drug ID BADD_D00165
Description Aripiprazole is an atypical antipsychotic orally indicated for treatment of schizophrenia, bipolar I, major depressive disorder, irritability associated with autism, and Tourette's[Label]. It is also indicated as an injection for agitation associated with schizophrenia or bipolar mania[Label]. Aripiprazole exerts its effects through agonism of dopaminic and 5-HT1A receptors and antagonism of alpha adrenergic and 5-HT2A receptors[Label,A4393]. Aripiprazole was given FDA approval on November 15, 2002[L6136].
Indications and Usage For the treatment of schizophrenia and related psychotic disorders.
Marketing Status Prescription; Discontinued
ATC Code N05AX12
DrugBank ID DB01238
KEGG ID D01164
MeSH ID D000068180
PubChem ID 60795
TTD Drug ID D0H3HM
NDC Product Code 48433-120; 59148-007; 68554-0095; 62332-099; 60505-2675; 59148-010; 76282-045; 68382-439; 27241-056; 71335-1903; 31722-829; 63629-7017; 46708-256; 16714-787; 60505-2674; 17856-0570; 59651-110; 43598-554; 70518-3380; 48433-115; 65862-662; 65862-680; 50090-4817; 65162-896; 33342-123; 70518-2565; 68788-7162; 13668-219; 76282-049; 71335-1980; 60429-451; 0904-6511; 0904-6656; 31722-820; 50370-0009; 48433-117; 16714-145; 50090-4160; 68554-0020; 55289-251; 70934-662; 59148-030; 43353-148; 46602-0045; 67877-432; 63629-7003; 46708-260; 68071-5062; 50370-0044; 70518-2508; 71335-1893; 42043-401; 27241-052; 50228-325; 68788-7733; 50090-4800; 46602-1031; 63739-413; 72865-185; 43547-304; 0904-6510; 43598-966; 59148-034; 70771-1454; 43547-303; 71335-0412; 27241-053; 60687-157; 29300-176; 43598-968; 76282-048; 43598-558; 59116-2901; 70771-1451; 46602-1029; 59148-018; 68382-083; 67877-433; 43547-306; 70518-1303; 50228-477; 69452-339; 68788-7808; 16729-279; 65162-902; 63415-0085; 70518-2765; 59148-011; 50228-324; 27241-054; 12828-0088; 70771-1456; 29300-178; 50090-5840; 67877-434; 43598-970; 50228-478; 62332-100; 50090-5839; 33342-126; 60505-2677; 46602-1032; 46602-0010; 31722-827; 72865-153; 72865-181; 53104-7628; 59148-045; 43598-967; 70518-2806; 46602-0006; 68788-7006; 46602-0026; 59148-029; 43598-555; 64220-112; 70518-2950; 33342-124; 50228-329; 70518-2584; 50090-4863; 16714-788; 60687-168; 70518-2869; 60505-2673; 13668-221; 43547-305; 43353-140; 72865-154; 16714-783; 72865-184; 33342-127; 62332-098; 71335-1935; 65862-666; 13668-216; 16729-280; 43353-180; 68382-085; 29300-179; 16714-141; 63629-6999; 65162-899; 65862-661; 43598-969; 0904-6514; 70518-2580; 16714-144; 70518-2567; 70518-2825; 70518-2736; 16714-146; 46602-0007; 66689-735; 58032-2005; 59148-072; 13668-217; 60429-446; 59148-032; 63187-965; 31722-830; 71335-1364; 65372-1121; 62332-097; 63739-070; 70518-2515; 16714-785; 50228-328; 70518-2536; 72865-183; 62332-101; 70518-2557; 0615-8375; 65862-663; 72865-182; 33342-122; 60505-2676; 43598-556; 71335-1682; 46602-0072; 50090-3941; 46602-0009; 43598-559; 46708-259; 68382-082; 50090-4936; 65691-0052; 43547-302; 46602-0008; 71205-480; 43598-965; 68382-084; 60429-449; 43547-307; 71335-1832; 71335-1515; 17856-0110; 50370-0055; 59148-006; 53747-031; 50228-327; 60505-3075; 50268-088; 70518-1263; 70518-2820; 13668-218; 50228-476; 72865-158; 50090-4665; 16729-278; 16714-786; 59148-008; 70518-2897; 72761-020; 68788-8089; 31722-819; 68788-7076; 65862-664; 70518-3011; 60687-213; 46602-0011; 72865-157; 29300-180; 76072-1002; 70518-2921; 46602-1030; 16729-282; 62332-102; 76282-047; 65841-140; 71335-1688; 70771-1455; 71335-1513; 46708-254; 48433-119; 60429-450; 65162-898; 60505-0404; 43353-147; 59148-031; 63739-074; 70771-1452; 46708-258; 0904-6509; 46708-255; 65162-897; 50268-091; 27241-051; 59148-019; 46602-1034; 76282-046; 46602-1033; 12658-0576; 0615-8259; 48433-118; 72865-155; 50228-480; 62332-103; 68788-7063; 0904-6512; 27241-055; 63629-7108; 50268-089; 53808-1101; 63739-078; 70518-3004; 68382-086; 70518-1421; 72865-180; 70518-2827; 50268-092; 16729-283; 66603-706; 68071-2394; 69452-338; 16729-281; 12658-0577; 70518-2514; 67877-431; 72865-156; 49706-1889; 68788-7749; 65862-665; 50268-087; 70518-2958; 69037-0058; 50228-475; 33342-125; 58623-0127; 63739-069; 70771-1453; 60429-447; 14445-019; 60429-448; 43598-557; 66603-705; 76282-044; 46602-0025; 50268-090; 71335-1687; 29300-177; 67835-0009; 31722-828; 71335-1892; 46708-261; 54838-570; 70518-0970; 60687-202; 71205-392; 63629-7774; 70518-3090; 67877-430; 16714-784; 29300-175; 70518-2974; 16714-143; 60687-179; 59148-033; 62332-104; 67877-435; 42043-400; 65096-0107; 13668-220; 16714-142; 46708-257; 50228-326; 48433-116; 65162-893; 59148-009; 50228-479; 0904-6513; 60687-191; 65162-901; 59116-2900; 71335-1711; 70518-2643
Synonyms Aripiprazole | 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone | Aripiprazol | Abilify | OPC 14597 | OPC-14597
Chemical Information
Molecular Formula C23H27Cl2N3O2
CAS Registry Number 129722-12-9
SMILES C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gamma-glutamyltransferase increased13.03.01.011--
Gastric ulcer haemorrhage24.07.02.003; 07.04.03.005--Not Available
Gastritis07.08.02.001--
Gastrooesophageal reflux disease07.02.02.003--
Gastroenteritis11.01.07.004; 07.19.03.0010.000763%Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal necrosis24.04.08.006; 07.15.01.0030.000572%
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.0040.000954%
Generalised tonic-clonic seizure17.12.01.0020.002861%Not Available
Gestational diabetes18.02.04.001; 14.06.01.008; 05.06.01.0080.003242%Not Available
Gingival bleeding24.07.02.010; 07.09.07.001--Not Available
Gingival pain07.09.04.001--
Gingivitis11.01.04.013; 07.09.03.003--
Glaucoma06.03.01.0020.001335%
Glomerular filtration rate decreased13.13.01.009--Not Available
Glossitis07.14.01.001--Not Available
Glossodynia07.14.02.001--Not Available
Glucose tolerance decreased13.02.02.004--Not Available
Glucose tolerance impaired14.06.02.001; 05.06.02.0010.001716%
Glucose urine13.13.02.016--Not Available
Glycosuria20.02.01.005--
Glucose urine present13.13.02.001--Not Available
Glycosylated haemoglobin decreased13.02.02.012--Not Available
Glycosylated haemoglobin increased13.02.02.0050.002098%Not Available
Goitre05.02.01.001; 14.11.01.008--Not Available
Gout15.01.06.001; 14.09.01.001--Not Available
Groin pain15.03.02.004--Not Available
Gynaecomastia21.05.04.003; 05.05.02.003--
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 42 Pages